A 3-Plex Methylation Assay Combined with the <i>FGFR3</i> Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine
Raju Kandimalla(Baylor University Medical Center), Ellen C. Zwarthoff(Erasmus MC), Lars Dyrskjøt(Aarhus University Hospital), Nikki van Leeuwen(Erasmus MC), Willemien Beukers(Erasmus University Rotterdam), Chris H. Bangma(Erasmus University Rotterdam), Angela A.G. van Tilborg(Erasmus MC), Torben F. Ørntoft(Aarhus University Hospital), Roy Masius(Erasmus MC), Hester F. Lingsma(Erasmus MC)
Cited by 59
Related Papers
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
|JAMA Oncology|2019|992
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654